Company research

Lifecore Biomedical, Inc. Common Stock (LFCR) stock fundamentals

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacture of hyaluronate acid in

As of 2026-10-08

Exchange
XNAS
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Company overview

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacture of hyaluronate acid in bulk form; and formulated and filled syringes, cartridges, and vials for injectable products used in treating a range of medical conditions and procedures. It also provides product development services include analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and production of materials for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.

Daily valuation snapshot

These values come from the daily market snapshot dated 2026-10-08. TTM means trailing twelve months. Use the market date when comparing LFCR with another company.

Daily close (USD)$6.43
Market capitalization (USD)$243,395,175.8
Price / earnings (TTM)Not reported
Price / book15.12

Read LFCR's valuation metrics

  1. Company size

    Lifecore Biomedical, Inc. Common Stock's recorded market capitalization is $243,395,175.8. It measures the market value of the company's equity, rather than its revenue or cash balance.

  2. Price relative to earnings

    P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.

  3. Price relative to book equity

    LFCR's recorded price-to-book ratio is 15.12. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.

Research Lifecore Biomedical, Inc. Common Stock with Aurora

Use the snapshot above to ask a specific question about LFCR. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.

Continue the research

Follow LFCR's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.

Aurora · AI research assistant

Try this in Aurora

Edit the request, then open it in Aurora. You choose when to send it.